Brain Monitoring Systems Market Outlook (2023 to 2033)

The brain monitoring systems market is likely to record a CAGR of 5.5% during the forecast period. The market holds a share of US$ 5.0 billion in 2023, while it is anticipated to cross a value of US$ 8.5 billion by 2033.

The brain monitoring systems market outlook states that the increased healthcare budget post-pandemic is helping authorities to focus more on brain treatment procedures. The overall response to the advanced techniques provides real-time tracking of brain activity and response to the medication.

The market for brain monitoring systems is influenced by several macroeconomic and industrial factors, which include device regulations, device safety, and device licensing, as per the market dynamics originating from disease epidemiology and procedure adoption rates. These factors are anticipated to flourish the demand for brain monitoring systems globally.

The research report on the brain monitoring systems market explains that the brain functionality and its matrix are going through a research and development phase. Vendors now try to build devices that help each kind of patient in monitoring their EEG readings while using advanced scanning modules.

This advanced neuromonitoring includes synchronous video recording that clears the documentation and clears the EEG system. The integration of AI and Machine Learning along with cloud documentation is likely to transform brain scanning and monitoring procedures in the future. These elements of the fourth industrial revolution, Industry 4.0, have an overall impact on healthcare solutions. Brain tracking and monitoring devices prevent the patient from getting strokes or nerve damage as it constantly delivers information to the concerned doctor.

Attributes Details
Brain Monitoring Systems Market CAGR (2023 to 2033) 5.5%
Brain Monitoring Systems Market Size (2023) US$ 5.0 billion
Brain Monitoring Systems Market Size (2033) US$ 8.5 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How is the Future Outlook for Brain Monitoring Systems Market in Comparison to the Historical Pattern? 

Short-term Growth (2017 to 2022): The global brain monitoring systems market registered a CAGR of 7.0%. Brain monitoring systems are used in neurological testing for the detection of any abnormality in the functioning of brain cells (neurons) that leads to the development of neurological disorders such as Parkinson's disease, epilepsy, dementia, sleep disorder, and Alzheimer's. These systems allow the observation and identification of the activity of neurons without the need for invasive neurosurgery.

Mid-term Growth (2022 to 2028): The market has added new elements such as AI and machine learning into the picture during the mid-term growth period. However, the pandemic slowed down the research and development pace, which has been reflected in the current running forecast period. Furthermore, the advanced sensory technology that gathers most information about brain vitals is supposed to restore growth by the end of 2033.

Long-term Growth (2028 to 2033): These are mostly preferred for scanning anatomical pathologies in the brain and understanding the structural and functional activity of neurons. Brain monitoring systems form an integral part of neuroimaging and radiological procedures. Considering these factors, the market is projected to witness a CAGR of 5.5% to reach US$ 8.5 billion by 2033.

What are the Main Drivers of the Brain Monitoring Systems Market?

Rising Usage of Brain Monitoring Sensors in Integrated Healthcare

Through bidirectional data gathering and processing of EEG signals, brain monitoring sensors support clinicians in keeping track of the brain under the influence of anesthesia.

There is a growing need to monitor patients with traumatic brain injuries to prevent l brain damage, particularly cerebral ischemia. The increasing demand for assessing Increased Intracranial Pressure (ICP) in patient monitoring will propel the demand for brain monitoring sensors.

Invasive monitoring is a complicated, painful, and hazardous procedure because it requires direct involvement with gentle brain tissue. As a result, both doctors and patients are enthusiastic about the adoption of non-invasive or minimally invasive brain monitoring equipment.

Wireless monitors are devices that diagnose without the use of wires or cords. Wireless headphones enable fully non-invasive readings and, in some situations, assessment of patients from the comfort of their own homes.

The recording device can be disconnected from the computer and interact with it via wireless signals from a distance of up to 10 or 20 meters using wireless technology. These devices are easy to use, inexpensive, and simple to maintain, and they only require one AAA battery. Handheld brain monitoring devices are small, light, and convenient to carry in one's hand.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors are Negatively Affecting Demand for Brain Monitoring Systems?

The high Cost of Brain Monitoring Devices and Surgeries limit the Market Growth

Lack of essential healthcare infrastructure, high treatment costs, and safety concerns about implant applications may all act as roadblocks to the expansion of the brain monitoring devices industry. Methods involving these devices are often costly, and equipment is considerably complicated. Product uptake may be hampered by the presence of negative reimbursement schemes and government laws.

Comparative View of Brain Monitoring Systems Market 

Brain Monitoring Systems Market:

Attributes Brain Monitoring Systems Market
CAGR (2023 to 2033) 5.5%
Market Value (2033) US$ 8.5 billion
Growth Factor The higher number of diseases related to brain injuries and brain paralysis is expanding the brain monitoring systems market size.
Opportunity The higher adoption of customized brain monitoring systems is creating opportunities for the market.
Key Trends Real-time EEG tracking along with anesthesia monitoring is shaping the trends in the market.

Medical Devices Market:

Attributes Medical devises Market
CAGR (2023 to 2033) 12.11%
Market Value (2033) US$ 976.86 million
Growth Factor Rising cases of epilepsy, Parkinson, and Alzheimer along with advanced technology are fueling the demand for wearable brain devices.
Opportunity Stroke-prone patients’ higher consumption of wearable brain devices is creating opportunities for the market.
Key Trends Increased clinical studies on wearable healthcare equipment are shaping the market trend.

Brain-Computer Interface Market:

Attributes Brain-Computer Interface Market
CAGR (2023 to 2033) 16.9%
Market Value (2033) US$ 39.28 billion
Growth Factor Common brain injuries or diseases like Parkinson's are penetrating high in the urban population, flourishing the adoption of brain-computer interface/
Opportunity Apart from clinical usage, the technology is used in virtual gaming along with military communication systems.
Key Trends Its usage in smart home appliances is shaping the trends for brain-computer interface systems.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Brain Monitoring Systems Market Country-wise Insights 

Regions Absolute Market Growth
The United States US$ 1.3 billion
The United Kingdom US$ 59.2 million
China US$ 472.1 million
Japan US$ 245.5 million
India US$ 244.9 million

Which Region leads the Market in terms of Market Share?

Rising Prevalence of Neurological Diseases to Fuel Sales of Brain Monitoring Products in the United States

Region Attributes
The United States Market CAGR (2023 to 2033) 6.4%
The United States Market Absolute Doller Growth (US$ million/billion) US$ 1.3 billion

According to the National Institute of Neurological Disorders and Stroke, nearly 30 million people in the United States suffer from one of the nearly 7,000 identified uncommon or ultra-rare disorders. Over 45% of uncommon diseases are associated with neurological symptoms. In the United States, the rising prevalence of various neurodegenerative and neurological disorders has led to increased innovation in mobile EEG devices, real-time monitoring, and alarms. Hence the demand for brain monitoring products is increasing. The United States is likely to cross a market share of US$ 2.7 billion by 2033.

What makes China the Leading Market in terms of CAGR?

Rapid Deployment of Non-invasive Brain Monitoring Devices in the Country

Region Attributes
Market in China CAGR (2023 to 2033) 7.6%
Market in China Absolute Doller Growth (US$ million/billion) US$ 472.1 million

China is anticipated to be the hotspot destination for investment opportunities for key players. It is due to the high diagnosis growth rate, research activities, quality improvisations, and increasing healthcare modernization. An increase in the number of senior citizens and patients with severe diseases, a rise in consumer spending, and the growing adoption of non-invasive brain monitoring devices are driving the market growth in China. The market in China is expected to reach a market valuation of US$ 905.9 million.

How will the Brain Monitoring Systems Market Expand across Japan?

Region Attributes
Market in Japan CAGR (2023 to 2033) 5.9%
Market in Japan Absolute Doller Growth (US$ million/billion) US$ 245.5 million

The brain monitoring system market in Japan is growing due to the rising prevalence of neurological illnesses and the availability of medical reimbursements. Higher healthcare spending and a more advanced healthcare infrastructure will contribute to an increase in demand for brain monitoring devices in the region.

An increased number of clinical trials for advanced brain monitoring technologies has been directed by the growing government financing for neuroscience. Another impact-rendering driver for market growth is the wide availability of insurance coverage. The market is expected to reach a value of US$ 563.9 million.

Category-wise Insights 

Segment Top Product Type
Top Sub-segment EEG Systems
CAGR (2018 to 2022) 7.8%
CAGR (2023 to 2033) 6.2%
Segment Top Modality
Top Sub-segment Standalone
CAGR (2018 to 2022) 6.8%
CAGR (2023 to 2033) 5.1%

Focus on Delivering Effective Treatment via Early Detection of Abnormalities Driving Adoption of EEG Systems.

Monitoring of neural signals along the scalp caused by the activation of neurons in the brain is known as Electroencephalography (EEG). EEG is a term used in clinical settings to describe the tracking of the brain's natural electrical stimulation during a short period, often 20-40 minutes, using many electrodes on the scalp.

The most common use of EEG systems in neurology is to diagnose epilepsy, as epileptic activity can cause obvious abnormalities in a regular EEG study. EEG systems are also used in the detection of unconsciousness, dementia, and brain death as a secondary clinical application.

The use of EEG machines has been fuelled by a desire to provide successful therapy through the early detection of problems, as this equipment allows for helpful therapies with minimal risk of neurological consequences. The EEG system segment is recording a CAGR of 6.2% during the forecast period.

Higher Portability Makes the Standalone Brain Monitoring System the First Choice

The changing lifestyle and advanced battery-based brain monitoring systems are gaining traction for standalone systems by modality. Expanding in the market, vendors design these standalone systems efficiently. These systems also work on the same EEG measures that track the patterns of electrical activity in the brain. The segment records a CAGR of 5.1% between 2023 and 2033.

Significant Increase in Usage of EEG Standard & MRI Systems for Brain Monitoring across Hospitals

Hospitals accounted for a 42.1% share of the brain monitoring systems market in 2022. Brain monitoring is a complicated procedure that necessitates the use of costly and advanced technology and systems usually available in hospitals.

Compared to small clinics and other end users, hospitals experience a significantly higher intake of patients. Brain monitoring devices put a significant financial strain on healthcare facilities in terms of maintenance expenditures; hospitals can tolerate such expenses. As a result, the majority of brain monitoring devices are utilized in hospitals.

Competition Scenario 

Key manufacturers of brain monitoring systems are focusing on marketing strategies to increase both their product portfolio as well as geographical presence.

Some other key market strategies followed by manufacturers include distribution & collaboration agreements to increase product reach, partnering with local as well as global retailers, and long-term partnerships with ambulatory surgical centers, clinics, hospitals and other distribution channels such as neonatal and pediatrics ICUs.

For instance:

In November 2021, Medtronic PLC., teamed up with Rune Labs, a leading supplier of neurological and psychiatric disease solutions, to leverage the latter's proprietary software system to integrate, analyze, and visualize information from its Percept PC Neurostimulator.

Major Contributors of the Brain Monitoring Systems Market are 

  • Neurosoft
  • Natus Medical Incorporated
  • Medtronic PLC
  • Integra Lifesciences
  • Compumedics Neuroscan
  • Masimo Corporation
  • Elekta AB
  • Advanced Brain Monitoring Inc.
  • Cadwell Laboratories
  • Nonin Medical Inc.
  • Nihon Kohden Corporation

Key Segments 

Brain Monitoring Systems Market by Product:

  • fNIRS
  • EEG Systems
  • MEG Systems
  • MRI Systems
  • Others

Brain Monitoring Systems Market by Modality:

  • Portable/Handheld Brain Monitoring Systems
  • Standalone Brain Monitoring Systems

Brain Monitoring Systems Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Pediatric & Neonatal Intensive Care Units

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Brain Monitoring Systems Market?

The market is valued at US$ 5.0 billion in 2023.

What is the Growth Forecast for the Brain Monitoring Systems Market?

The market is forecast to register a CAGR of 5.5% through 2033.

What was the Historical Market Growth Outlook?

From 2017 to 2022, the market secured a CAGR of 7.0%.

What is the Expected Size of the Market by 2033?

By 2033, the market is estimated to reach US$ 8.5 billion.

What is the CAGR of China’s Market?

China’s market is expected to surge at a 7.6% CAGR.

Table of Content
1. Executive Summary | Brain Monitoring Systems Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyers

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. MRI Systems

            5.3.1.1. fMRI Systems

            5.3.1.2. Others MRI Systems

        5.3.2. EEG Systems

            5.3.2.1. Simplified EEG Systems

            5.3.2.2. Other EEG Systems

        5.3.3. MEG Systems

        5.3.4. fNIRS Systems

        5.3.5. Other Systems

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Modality

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Modality, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Modality, 2023 to 2033

        6.3.1. Portable/ Handheld

        6.3.2. Standalone

    6.4. Y-o-Y Growth Trend Analysis By Modality, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033

7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Systems

        7.3.3. Clinics

        7.3.4. Pediatric & Neonatal ICUS

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. Asia Pacific Excluding Japan

        8.3.6. Japan

        8.3.7. Middle East & Africa (MEA)

    8.4. Market Attractiveness Analysis By Region

9. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Modality

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Modality

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Argentina

            10.2.1.4. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Modality

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Modality

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. UK

            11.2.1.5. Spain

            11.2.1.6. Benelux

            11.2.1.7. Nordic

            11.2.1.8. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Modality

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Modality

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Russia

            12.2.1.2. Poland

            12.2.1.3. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Modality

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Modality

        12.3.4. By End User

    12.4. Key Takeaways

13. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. ANZ

            13.2.1.3. India

            13.2.1.4. Association of Southeast Asian Nations

            13.2.1.5. Rest of APEJ

        13.2.2. By Product Type

        13.2.3. By Modality

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Modality

        13.3.4. By End User

    13.4. Key Takeaways

14. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

        14.2.2. By Product Type

        14.2.3. By Modality

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Modality

        14.3.4. By End User

    14.4. Key Takeaways

15. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. North Africa

            15.2.1.3. South Africa

            15.2.1.4. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Modality

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Modality

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Modality

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Modality

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Modality

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Modality

            16.4.2.3. By End User

    16.5. Argentina

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Modality

            16.5.2.3. By End User

    16.6. Germany

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Modality

            16.6.2.3. By End User

    16.7. Italy

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Modality

            16.7.2.3. By End User

    16.8. France

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Modality

            16.8.2.3. By End User

    16.9. UK

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Modality

            16.9.2.3. By End User

    16.10. Spain

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Modality

            16.10.2.3. By End User

    16.11. Benelux

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Modality

            16.11.2.3. By End User

    16.12. Nordic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Modality

            16.12.2.3. By End User

    16.13. Russia

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Modality

            16.13.2.3. By End User

    16.14. Poland

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Modality

            16.14.2.3. By End User

    16.15. China

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Modality

            16.15.2.3. By End User

    16.16. ANZ

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Modality

            16.16.2.3. By End User

    16.17. India

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Modality

            16.17.2.3. By End User

    16.18. Association of Southeast Asian Nations

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Modality

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Modality

            16.19.2.3. By End User

    16.20. GCC Countries

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Modality

            16.20.2.3. By End User

    16.21. North Africa

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Modality

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Modality

            16.22.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Modality

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Neurosoft

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Natus Medical Incorporated

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Medtronic PLC

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Integra Lifesciences

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Compumedics Neuroscan

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Masimo Corporation

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Elekta AB

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Advanced Brain Monitoring Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Cadwell Laboratories

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Nonin Medical Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Nihon Kohden Corporation

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology
Recommendations

Healthcare

Deep Brain Stimulator Market

March 2016

REP-GB-1338

June 2024

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Brain Monitoring Systems Market